# Nanobody-Protease
Using IgFold for de novo prediction of therapeutic nanobody structures and  machine learning-based protein-protein docking models (e.g., HDOCK, DiffDock-PP)  to investigate interactions between nanobodies and cancer-associated fibroblast activation proteins 
